Exacerbation of psoriasis following hydroxychloroquine in a patient with suspected COVID-19.
Identifieur interne : 000497 ( Main/Exploration ); précédent : 000496; suivant : 000498Exacerbation of psoriasis following hydroxychloroquine in a patient with suspected COVID-19.
Auteurs : I N Nur Sultan Öncü [Turquie] ; Dilara Güler [Turquie] ; Gülhan Gürel [Turquie]Source :
- Dermatologic therapy [ 1529-8019 ] ; 2021.
Descripteurs français
- KwdFr :
- MESH :
- diagnostic : Psoriasis.
- effets indésirables : Hydroxychloroquine.
- induit chimiquement : Psoriasis.
- traitement médicamenteux : Psoriasis.
- Humains.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Hydroxychloroquine.
- chemically induced : Psoriasis.
- diagnosis : Psoriasis.
- drug therapy : COVID-19, Psoriasis.
- Humans, SARS-CoV-2.
DOI: 10.1111/dth.14806
PubMed: 33486832
PubMed Central: PMC7995161
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Exacerbation of psoriasis following hydroxychloroquine in a patient with suspected COVID-19.</title><author><name sortKey="Oncu, I N Nur Sultan" sort="Oncu, I N Nur Sultan" uniqKey="Oncu I" first="I N Nur Sultan" last="Öncü">I N Nur Sultan Öncü</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar</wicri:regionArea><wicri:noRegion>Afyonkarahisar</wicri:noRegion></affiliation></author><author><name sortKey="Guler, Dilara" sort="Guler, Dilara" uniqKey="Guler D" first="Dilara" last="Güler">Dilara Güler</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar</wicri:regionArea><wicri:noRegion>Afyonkarahisar</wicri:noRegion></affiliation></author><author><name sortKey="Gurel, Gulhan" sort="Gurel, Gulhan" uniqKey="Gurel G" first="Gülhan" last="Gürel">Gülhan Gürel</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar</wicri:regionArea><wicri:noRegion>Afyonkarahisar</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2021">2021</date><idno type="RBID">pubmed:33486832</idno><idno type="pmid">33486832</idno><idno type="doi">10.1111/dth.14806</idno><idno type="pmc">PMC7995161</idno><idno type="wicri:Area/Main/Corpus">000446</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000446</idno><idno type="wicri:Area/Main/Curation">000446</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000446</idno><idno type="wicri:Area/Main/Exploration">000446</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Exacerbation of psoriasis following hydroxychloroquine in a patient with suspected COVID-19.</title><author><name sortKey="Oncu, I N Nur Sultan" sort="Oncu, I N Nur Sultan" uniqKey="Oncu I" first="I N Nur Sultan" last="Öncü">I N Nur Sultan Öncü</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar</wicri:regionArea><wicri:noRegion>Afyonkarahisar</wicri:noRegion></affiliation></author><author><name sortKey="Guler, Dilara" sort="Guler, Dilara" uniqKey="Guler D" first="Dilara" last="Güler">Dilara Güler</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar</wicri:regionArea><wicri:noRegion>Afyonkarahisar</wicri:noRegion></affiliation></author><author><name sortKey="Gurel, Gulhan" sort="Gurel, Gulhan" uniqKey="Gurel G" first="Gülhan" last="Gürel">Gülhan Gürel</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar</wicri:regionArea><wicri:noRegion>Afyonkarahisar</wicri:noRegion></affiliation></author></analytic><series><title level="j">Dermatologic therapy</title><idno type="eISSN">1529-8019</idno><imprint><date when="2021" type="published">2021</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>COVID-19 (drug therapy)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (adverse effects)</term><term>Psoriasis (chemically induced)</term><term>Psoriasis (diagnosis)</term><term>Psoriasis (drug therapy)</term><term>SARS-CoV-2 (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Humains (MeSH)</term><term>Hydroxychloroquine (effets indésirables)</term><term>Psoriasis (diagnostic)</term><term>Psoriasis (induit chimiquement)</term><term>Psoriasis (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Psoriasis</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Psoriasis</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Psoriasis</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term><term>Psoriasis</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr"><term>Psoriasis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Psoriasis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>SARS-CoV-2</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">33486832</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-8019</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Dermatologic therapy</Title><ISOAbbreviation>Dermatol Ther</ISOAbbreviation></Journal><ArticleTitle>Exacerbation of psoriasis following hydroxychloroquine in a patient with suspected COVID-19.</ArticleTitle><Pagination><MedlinePgn>e14806</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/dth.14806</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Öncü</LastName><ForeName>Işın Nur Sultan</ForeName><Initials>INS</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-9874-9823</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Güler</LastName><ForeName>Dilara</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gürel</LastName><ForeName>Gülhan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dermatol Ther</MedlineTA><NlmUniqueID>9700070</NlmUniqueID><ISSNLinking>1396-0296</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011565" MajorTopicYN="Y">Psoriasis</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>01</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>24</Day><Hour>20</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33486832</ArticleId><ArticleId IdType="doi">10.1111/dth.14806</ArticleId><ArticleId IdType="pmc">PMC7995161</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Liu J, Cao R, Xu M, et al. Hydroxychloroquine, a less toxic derivative of chloroquine is effective in inhibiting SARS-CoV2 infection in vitro. Cell Discov. 2020;6:16.</Citation></Reference><Reference><Citation>Wang WM, Wang KY, Wang T, Jin HZ, Fang K. Hydroxychloroquine-induced psoriasis-form Erythroderma in a patient with systemic lupus erythematosus. Chin Med J (Engl). 2018;131:1887-1888.</Citation></Reference><Reference><Citation>Sharma AN, Mesinkovska NA, Paravar T. Characterizing the adverse dermatologic effects of hydroxychloroquine: a systematic review. J Am Acad Dermatol. 2020;83:563-578.</Citation></Reference><Reference><Citation>Balak DM, Hajdarbegovic E. Drug-induced psoriasis: clinical perspectives. Psoriasis (Auckl). 2017;7:87-94.</Citation></Reference><Reference><Citation>Sachdeva M, Mufti A, Maliyar K, Lytvyn Y, Yeung J. Hydroxychloroquine effects on psoriasis: a systematic review and a cautionary note for COVID-19 treatment. J Am Acad Dermatol. 2020;83:579-586.</Citation></Reference><Reference><Citation>Kutlu Ö, Metin A. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: will cases of psoriasis increase after COVID-19 pandemic? Dermatol Ther. 2020;33:e13383.</Citation></Reference><Reference><Citation>McCoy S, Nagaraja V, Paviol S, Gudjonsson JE, Kahlenberg JM. Exacerbation of psoriasis due to hydroxychloroquine. Arch Med. 2015;7:1-3.</Citation></Reference><Reference><Citation>Saxena VN, Dogra J. Long-term oral azithromycin in chronic plaque psoriasis: a controlled trial. Eur J Dermatol. 2010;20:329-333.</Citation></Reference><Reference><Citation>Carugno A, Gambini DM, Raponi F, et al. COVID-19 and biologics for psoriasis: a high-epidemic area experience-Bergamo, Lombardy, Italy. J Am Acad Dermatol. 2020;83:292-294.</Citation></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Turquie</li></country></list><tree><country name="Turquie"><noRegion><name sortKey="Oncu, I N Nur Sultan" sort="Oncu, I N Nur Sultan" uniqKey="Oncu I" first="I N Nur Sultan" last="Öncü">I N Nur Sultan Öncü</name></noRegion><name sortKey="Guler, Dilara" sort="Guler, Dilara" uniqKey="Guler D" first="Dilara" last="Güler">Dilara Güler</name><name sortKey="Gurel, Gulhan" sort="Gurel, Gulhan" uniqKey="Gurel G" first="Gülhan" last="Gürel">Gülhan Gürel</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000497 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000497 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:33486832
|texte= Exacerbation of psoriasis following hydroxychloroquine in a patient with suspected COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:33486832" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |